Intranasal Ketamine as a Sedative for Venipuncture

• Status: Completed
• Trial end date: 2016-10-01
• Target enrollment: 0
• Participant gender: All

Summary

Randomized clinical trial, controlled, double-blind, parallel two-arm.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hospital de Clinicas de Porto Alegre
• Treatments: Hypnotics and Sedatives; Ketamine; Pharmaceutical Solutions

Criteria

Inclusion Criteria:

• Children hospitalized in the Pediatric Inpatient Units, with the presence of legal guardian;

• Aged 3 months to 12 years;

• Requiring venipuncture independent research.

Exclusion Criteria:

• Severe neurological sequelae;

• Patients who need immediate venipuncture at risk;

• Presence of active nosebleeds;

• Patients using drugs sedative and analgesic continuos;

• Children who have experienced clinical change with ketamine.